Results 251 to 260 of about 628,495 (277)

<i>RGS4</i> in gastric cancer: A multifaceted regulator of focal-adhesion-kinase -phosphatidyl-inositol-3-kinase - protein-kinase-B signaling and epithelial-mesenchymal transition beyond tumor progression. [PDF]

World J Gastroenterol
Yang Y, Chen WM.
europepmc   +1 more source

Epigenetic Regulation of Higher-Order Chromatin Structure (HOCS) and Its Implication in Human Diseases. [PDF]

Cancers (Basel)
Ladel L, Sailo B, Das P, Lin ES, Tan WY, Chhoda A, Tang H, Ang-Olson O, He L, John N, Kratz JD, Sharma A, Ahuja N.   +12 more
europepmc   +1 more source

POM121 O-GlcNAcylation facilitates bone metastasis in non-small cell lung cancer through enhanced c-MYC nuclear import and ECM reprogramming. [PDF]

Oncogene
Ren YZ, Zhao MN, Du FL, Wu L, Wang L, Lou JT.   +5 more
europepmc   +1 more source

From mechanism to phenotype: What fits in a basket trial

Epilepsia, EarlyView.
Kette D. Valente
wiley   +1 more source

Deubiquitinating Enzyme OTUDs: Focus on Cancers and Antiviral Response. [PDF]

Oncol Res
Chen L, Dong R, Huan X.
europepmc   +1 more source

Transposons disrupt genomic stability and trigger cancers. [PDF]

Front Cell Infect Microbiol
Dong W, Li M, Li P, Hou X, He F, Ji S.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Oncogenic protein tyrosine kinases

Cellular and Molecular Life Sciences, 2004
Platelet-derived growth factor receptors (PDGFRs) and their ligands, platelet-derived growth factors (PDGFs) play critical roles in mesenchymal cell migration and proliferation. In embryogenesis the PDGFR/PDGF system is essential for the correct development of the kidney, cardiovascular system, brain, lung and connective tissue.
K. Pulford, L. Lamant, E. Espinos, Q. Jiang, L. Xue, F. Turturro, G. Delsol, S. W. Morris   +7 more
  +12 more sources

Oncogenic proteins as tumor antigens

Current Opinion in Immunology, 1996
Human immune responses to oncogenic proteins have been reported and are continuing to be defined. Immunity to nonmutated overexpressed oncoproteins as well as to mutated or unique cancer-specific oncoproteins has been identified. Immune system based treatments targeting oncogenic proteins have shown therapeutic efficacy in animals models and are ...
M L, Disis, M A, Cheever
openaire   +2 more sources